Consolidated Statements Of Cash Flows (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 25, 2011	Dec. 26, 2010	Dec. 27, 2009
Cash flows from operating activities:
Net loss	$ (74,322)	$ (22,638)	$ (35,765)
Adjustments to reconcile net loss:
Depreciation	40,348	40,896	46,015
Amortization	11,227	12,193	13,177
Deferred income taxes	10,727	30,025	10,948
Uncertain tax positions	(25)	(1,667)	(4,771)
Intraperiod tax allocation			(1,145)
Income on investments			(701)
Goodwill and other asset impairment	32,645		84,220
Provision for doubtful accounts	2,143	2,626	4,087
Gain on insurance recovery		(956)	(1,915)
Write-off of previously deferred debt issuance costs		1,772
Net gain related to divestiture of discontinued operations			(8,873)
Change in assets and liabilities:
Income taxes refundable	933	26,697	(22,587)
Company owned life insurance (cash surrender value less policy loans including repayments)	1,832	(127)	(1,216)
Accounts receivable and inventory	4,559	(956)	(669)
Accounts payable, accrued expenses and other liabilities	(7,457)	17,321	(28,985)
Retirement plan contributions	(10,549)	(20,000)	(15,000)
Other, net	4,635	520	(3,042)
Net cash provided by operating activities	16,696	85,706	33,778
Cash flows from investing activities:
Capital expenditures	(19,053)	(26,482)	(18,453)
Proceeds from sales of discontinued operations and investments			17,625
Insurance proceeds related to machinery and equipment			3,120
Collection of note receivable			5,000
Other, net	448	692	2,991
Net cash (used) provided by investing activities	(18,605)	(25,790)	10,283
Cash flows from financing activities:
Increase in bank debt	112,500	134,156	215,700
Repayment of bank debt	(118,786)	(476,653)	(233,840)
Proceeds from issuance of senior notes		293,070
Debt issuance costs		(12,078)
Other, net	(524)	217	169
Net cash used by financing activities	(6,810)	(61,288)	(17,971)
Net (decrease) increase in cash and cash equivalents	(8,719)	(1,372)	26,090
Cash and cash equivalents at beginning of year	31,860	33,232	7,142
Cash and cash equivalents at end of year	$ 23,141	$ 31,860	$ 33,232